Diagnosis, Treatment, and Prevention of Colorectal Cancer Amid Abnormal Lipid Metabolism

Launched by TIANJIN UNION MEDICAL CENTER · Mar 19, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how certain fats in the body, inflammation, and colorectal cancer (CRC) are connected. Researchers are creating a detailed database of CRC patients that includes information about their health, body measurements, imaging tests, and specific markers related to fat metabolism and inflammation. The main goal is to discover how these factors influence the development and progression of CRC and to improve patient care through a personalized prevention strategy. This strategy will involve predicting risks early, offering targeted treatments, and providing comprehensive support after surgery.

To be eligible for the trial, participants should be between 20 and 80 years old and have a confirmed diagnosis of colorectal cancer. They will need to give their consent to join the study. Unfortunately, individuals under 20 or over 80, those who cannot perform daily activities, or those with certain infectious diseases cannot participate. If you join the study, you can expect to contribute valuable information that may help improve CRC treatment and prevention in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 20-80 years, confirmed CRC diagnosis, consent to participate in the study.
• Exclusion Criteria:
• • Age \<20 or \>80 years; inability to perform activities of daily living; presence of infectious diseases; lack of communication and cognitive abilities; refusal to participate in the study.